BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 188 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,162,714 | -19.9% | 49,625 | +12.9% | 0.01% | -23.1% |
| Q1 2024 | $1,452,207 | +39.4% | 43,953 | +14.8% | 0.01% | +30.0% |
| Q4 2023 | $1,041,900 | +63.2% | 38,277 | +44.2% | 0.01% | +42.9% |
| Q3 2023 | $638,407 | +9.7% | 26,545 | +45.7% | 0.01% | +16.7% |
| Q2 2023 | $581,892 | +19.1% | 18,224 | +14.2% | 0.01% | +20.0% |
| Q1 2023 | $488,695 | +3.8% | 15,960 | +32.6% | 0.01% | -16.7% |
| Q4 2022 | $470,806 | -20.2% | 12,038 | -2.8% | 0.01% | -25.0% |
| Q3 2022 | $590,000 | +26.1% | 12,380 | +2.4% | 0.01% | +33.3% |
| Q2 2022 | $468,000 | -29.7% | 12,085 | +3.9% | 0.01% | -14.3% |
| Q1 2022 | $666,000 | -18.9% | 11,631 | +12.9% | 0.01% | -22.2% |
| Q4 2021 | $821,000 | -8.4% | 10,298 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $896,000 | – | 10,298 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |